747097
Last Update Posted: 2011-02-10
Recruiting has ended
All Genders accepted | 18 Years + |
43 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study
The purpose of this phase II study is to assess the efficacy of combined chemotherapy using gemcitabine and cetuximab for advanced cholangiocarcinoma, excluding gallbladder cancer.
Eligibility
Relevant conditions:
Time to Progression
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov